Treatment of cutaneous lupus erythematosus with etretinate
DOI:
https://doi.org/10.2340/0001555565324329Abstract
Nineteen patients with different clinical subsets of cutaneous lupus erythematosus (LE) were treated with the aromatic retinoid etretinate. In 11 of them excellent or good treatment results were obtained within two to six weeks. Best response to etretinate therapy was seen in male patients with discoid lupus erythematosus. Etretinate should prove a valuable drug in LE therapy.Downloads
Download data is not yet available.
Downloads
Published
1985-07-01
How to Cite
Ruzicka, T., Meurer, M., & Braun-Falco, O. (1985). Treatment of cutaneous lupus erythematosus with etretinate. Acta Dermato-Venereologica, 65(4), 324–329. https://doi.org/10.2340/0001555565324329
Issue
Section
Articles
License
Copyright (c) 1985 Acta Dermato-VenereologicaAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
